RAFA   $0.4  -4.45% Market Closed

Last Events:

2023-03-30 Trend pattern changed from нисходящий треугольник to нисходящий клин.

2023-03-30 Signal in Stochastic changed from bullish weakening to bearish recovery. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

2023-03-30 Trend Power changed from to slow.

2023-03-30 Trend changed from up and flat to turning down.

2023-03-29 Trend pattern changed from нисходящий клин to нисходящий треугольник.

2023-03-29 Signal in Stochastic changed from bearish recovery to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: main and signal line crossing.

2023-03-29 Trend Power changed from slow to .

2023-03-29 Trend changed from turning down to up and flat.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy -
rsi Buy ActivelyBuy -
macd - - -
stoch - - -
ma20 ActivelyBuy ActivelyBuy -
ma50 - - -
ma100 Buy ActivelyBuy -
Candlestick PatternMarch 13, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US75062C1009
Website https://rafarma.si
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.